Chemed Corporation
NYQ: CHE📈 ZcoreAI Score
Our AI model analyzes Chemed Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get CHE Z-Score →About Chemed Corporation
📊 Fundamental Analysis
Chemed Corporation demonstrates a profit margin of 10.5%, which is below the sector average, suggesting competitive pressure.
The company recently reported -0.1% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is 25.3%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.
At a current price of $385.84, CHE currently trades near the bottom of its 52-week range (9%), indicating potential value or weakness (Range: $365.21 - $604.91).
💰 Valuation Insight
CHE is valued broadly in line with the sector at a PE of 21.05. Analysts expect earnings growth, as indicated by a lower forward PE.